Neumora Therapeutics, Inc. (NMRA) has 22 open-market insider trades by 9 insiders since 2023. Over the last six months insiders net sold $702K. The most active filer is Kristina Burow, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Kristina Burow | Dir10% Owner | — | 8 | $41.1M | 2025-10-27 |
| Robert Nelsen | 10% Owner | — | 4 | $30.4M | 2023-09-29 |
| AMGEN Inc. | 10% Owner | — | 1 | $30.0M | 2023-09-19 |
| ARCH Venture Fund XII, L.P. | 10% Owner | — | 2 | $2.0M | 2023-11-14 |
| ARCH Venture Partners XII, LLC | 10% Owner | — | 1 | $753K | 2023-12-08 |
| Daljit Singh Aurora | — | — | 3 | $724K | 2026-08-21 |
| Henry O. Gosebruch | CEOPres | — | 1 | $189K | 2024-02-14 |
| Paul L. Berns | — | — | 1 | $34K | 2026-02-17 |
| Joshua Pinto | CFO | — | 1 | $21K | 2026-02-17 |
| ARCH Venture Partners VIII, LLC | 10% Owner | — | 0 | — | 2023-09-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Daljit Singh Aurora | — | Sell | $270K | 2026-08-20 |
| Daljit Singh Aurora | — | Sell | $432K | 2026-08-17 |
| Joshua Pinto | President | Sell | $21K | 2026-02-17 |
| Michael Lee Milligan | — | Sell | $5K | 2026-02-17 |
| Daljit Singh Aurora | — | Sell | $22K | 2026-02-17 |
| Paul L. Berns | — | Sell | $34K | 2026-02-17 |
Companies that share insiders with NMRA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Daljit Singh Aurora | — | Sell | $615K | 2025-11-11 |
| Kristina Burow | Director & 10% Owner | Buy | $5.0M | 2025-10-27 |
| Paul L. Berns | — | Sell | $23K | 2025-02-18 |
| Robert A. Lenz | Head of R&D | Sell | $9K | 2025-02-18 |
| Joshua Pinto | President | Sell | $13K | 2025-02-18 |
| Daljit Singh Aurora | Chief Strategy Officer | Sell | $14K | 2025-02-18 |
| Michael Lee Milligan | — | Sell | $3K | 2025-02-18 |
| Matthew K. Fust | Director | Sell | $742K | 2024-10-17 |
| Robert A. Lenz | — | Sell | $416K | 2024-10-09 |